Achieving Efficient Manufacturing and Quality Assurance through Synthetic Cell Therapy Design

Publication date: 5 January 2017
Source:Cell Stem Cell, Volume 20, Issue 1
Author(s): Yonatan Y. Lipsitz, Patrick Bedford, Anthony H. Davies, Nicholas E. Timmins, Peter W. Zandstra
New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex cellular systems, ultimately increasing patient access to living therapeutics.

Teaser

New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex cellular systems, ultimately increasing patient access to living therapeutics.


http://ift.tt/2iXjFPS